FIELD: medicine.
SUBSTANCE: invention relates to medicine, particularly to experimental oncology and prevention of carcinogenic effect of diethylnitrosamine in experimental animals. For this purpose a 100 mg/l portion of diethylnitrosamine is administered daily for 4 months together with an anticarcinogen, which is administered with food, 5 days before administering diethylnitrosamine. The anticarcinogen used is Essentiale N, in a dose of 75 mg/kg for nine months.
EFFECT: effective prevention of carcinogenesis in specific experimental conditions.
8 dwg, 2 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
PREVENTION METHOD OF CARCINOGENIC ACTION OF DIETHYL NITROSAMINE IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2358724C1 |
METHOD OF PREVENTION OF CARCINOGENIC ACTION OF DIETHYLNITROSAMINE IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2358747C1 |
METHOD FOR PREVENTION OF CANCEROGENIC EFFECT OF DIETHYLNITROSAMINE IN EXPERIMENTAL ANIMALS | 2014 |
|
RU2568587C2 |
METHOD OF PREVENTING CANCEROGENIC ACTION OF METHYLNITROSOUREA IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2410114C1 |
METHOD FOR PREVENTION OF CANCEROGENIC ACTION OF METHYLNITROSOUREA IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2410093C1 |
RHODANINE DERIVATIVE AND AGENT FOR PREVENTING MALIGNANT DISEASES | 2013 |
|
RU2521390C1 |
MEDICINAL AGENT FOR CANCER PREVENTION | 2006 |
|
RU2328294C1 |
CANCER PREVENTION "CLAMIN" REMEDY | 1993 |
|
RU2034560C1 |
AGENT FOR CANCER PROPHYLAXIS | 2002 |
|
RU2219935C1 |
AGENT FOR CANCER PROPHYLAXIS | 2005 |
|
RU2290178C1 |
Authors
Dates
2009-08-10—Published
2008-02-06—Filed